Your browser doesn't support javascript.
loading
A thermostable, closed, SARS-CoV-2 spike protein trimer.
Xiaoli Xiong; Kun Qu; Katarzyna A Ciazynska; Myra Hosmillo; Andrew P Carter; Zunlong Ke; Sjors H.W. Scheres; Laura Bergamaschi; Guinevere L. Grice; Ying Zhang; - The CITIID-NIHR COVID-19 BioResource Collaboration; James A. Nathan; Stephen Baker; Leo C. James; Helen E. Baxendale; Ian Goodfellow; John A.G. Briggs.
Affiliation
  • Xiaoli Xiong; Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
  • Kun Qu; Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
  • Katarzyna A Ciazynska; Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
  • Myra Hosmillo; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK
  • Andrew P Carter; Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
  • Zunlong Ke; Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
  • Sjors H.W. Scheres; Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
  • Laura Bergamaschi; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, UK
  • Guinevere L. Grice; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, UK
  • Ying Zhang; Precision Medicine Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, Guangdong, China
  • - The CITIID-NIHR COVID-19 BioResource Collaboration; -
  • James A. Nathan; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, UK
  • Stephen Baker; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, UK
  • Leo C. James; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
  • Helen E. Baxendale; Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
  • Ian Goodfellow; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK
  • John A.G. Briggs; Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
Preprint in English | bioRxiv | ID: ppbiorxiv-152835
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
The spike (S) protein of SARS-CoV-2 mediates receptor binding and cell entry and is the dominant target of the immune system. S exhibits substantial conformational flexibility. It transitions from closed to open conformations to expose its receptor binding site, and subsequently from prefusion to postfusion conformations to mediate fusion of viral and cellular membranes. S protein derivatives are components of vaccine candidates and diagnostic assays, as well as tools for research into the biology and immunology of SARS-CoV-2. Here we have designed mutations in S which allow production of thermostable, crosslinked, S protein trimers that are trapped in the closed, pre-fusion, state. We have determined the structures of crosslinked and non-crosslinked proteins, identifying two distinct closed conformations of the S trimer. We demonstrate that the designed, thermostable, closed S trimer can be used in serological assays. This protein has potential applications as a reagent for serology, virology and as an immunogen.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2020 Document type: Preprint
...